Ralivia 300 mg (Tramadol Hydrochloride TABLET (EXTENDED-RELEASE)) 300 MG

Ralivia 300 mg is an extended-release tramadol hydrochloride tablet used for managing moderate to severe pain. This prescription medication is designed for oral use and is manufactured by Bausch Health, Canada Inc.

Strength

300 MG

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ralivia 300 mg is primarily used for the management of moderate to severe pain that requires around-the-clock, long-term treatment. Tramadol hydrochloride, the active ingredient, is an opioid agonist that works by binding to opioid receptors in the brain to alter the perception of pain. This medication is often prescribed for conditions that cause chronic pain, such as arthritis or nerve damage. What is Ralivia 300 mg used for? It is typically used for pain relief in adults who need extended-release pain management.

Side Effects

Common effects of Ralivia 300 mg may include dizziness, nausea, constipation, and headache. Some users might experience drowsiness or vomiting. These effects can vary from person to person and may not affect everyone who takes the medication. It is important to monitor how your body responds to the medication and consult a healthcare provider if any effects are concerning.

Precautions & Warnings

Ralivia 300 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication should not be crushed, chewed, or broken, as it is designed for extended-release. Keep the medication out of reach of children and pets. Always store it in a cool, dry place away from direct sunlight.

Avoid Interactions

Ralivia 300 mg may interact with other medications, including alcohol, antidepressants, and other opioids. Combining tramadol hydrochloride with alcohol or other central nervous system depressants can increase the risk of severe side effects, such as respiratory depression. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Ralivia 300 mg is used for managing moderate to severe pain that requires long-term, around-the-clock treatment.

Ralivia 300 mg should be taken orally, whole, with or without food, as directed by your healthcare provider.

Common side effects may include dizziness, nausea, constipation, and headache.

No, Ralivia 300 mg tablets should not be crushed, chewed, or broken as they are designed for extended-release.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.